Form 4: Artivion Director Sells 4,200 Shares Under 10b5-1 Plan
Insider Transaction Report
Artivion Director Elizabeth A. Hoff reported the sale of 4,200 shares of common stock at a weighted average price of $45.098, executed under a Rule 10b5-1 plan.
Summary
- Elizabeth A. Hoff, a Director of Artivion, Inc. (AORT), reported a transaction involving the company's common stock.
- On November 18, 2025, Ms. Hoff disposed of 4,200 shares of common stock.
- The shares were sold at a weighted average price of $45.098 per share.
- The price range for the sales was between $44.89 and $45.295.
- Following this transaction, Ms. Hoff beneficially owns 27,189 shares of Artivion common stock directly.
- The transaction was made pursuant to a contract, instruction, or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Sentiment
Score: 5
Explanation: A director's sale of shares, while reducing their direct stake, was conducted under a pre-arranged 10b5-1 plan, which often indicates personal financial planning rather than a reaction to new company-specific information. This mitigates potential negative sentiment.
Positives
- The transaction was made pursuant to a Rule 10b5-1(c) plan, indicating a pre-scheduled sale rather than a reaction to new, negative information, which can mitigate concerns about insider trading.
Negatives
- A director's sale of shares, even if pre-planned, reduces their direct ownership in the company.
Risks
- Insider selling, even under a 10b5-1 plan, can sometimes be perceived negatively by the market, potentially leading to short-term downward pressure on the stock price.
Future Outlook
NA
Industry Context
NA
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Insider Trading Plan Disclosure | The transaction was made pursuant to a contract, instruction, or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). | 11/18/2025 | This indicates a pre-scheduled transaction, which can help mitigate concerns about insider trading based on material non-public information. |
Stakeholder Impact
- Shareholders: May observe a director reducing their stake, potentially influencing short-term sentiment, though the 10b5-1 plan provides context.
Key Dates
| Date | Description |
|---|---|
| 11/18/2025 | Date of earliest transaction (sale of common stock) |
| 11/19/2025 | Signature date of reporting person for the filing |
Recommendation
holdThe sale of 4,200 shares by a director, while noteworthy, was executed under a Rule 10b5-1 plan, suggesting a pre-determined personal financial strategy rather than a reaction to new company developments. This transaction represents a relatively small portion of the director's total beneficial ownership (27,189 shares remaining). Without additional context such as a broader pattern of insider selling or significant company news, this single transaction does not warrant a change from a 'hold' position.
Keywords
Artivion, AORT, insider trading, Form 4, stock sale, director transaction, Elizabeth Hoff, 10b5-1 plan
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.